Oral Session 1-8C Malignant Lymphoma: Prognostic factors

[OS1-8C-1] Assessment of prognostic factors of pediatric EBV-HLH treated with the HLH-2004 protocol

Ryu Yanagisawa^1,2,3, Yozo Nakazawa², Kazuyuki Matsuda⁴, Takahiro Yasumi⁵, Hirokazu Kanegane⁶, Shouichi Ohga⁷, Akira Morimoto⁸, Akiko Saito³, Keizo Horibe³, Eiichi Ishii^3,9 (1.Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan, 2.Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan, 3.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 4.Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan, 5.Department of Pediatrics, Kyoto University, Kyoto, Japan, 6.Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan, 7.Department of Pediatrics, Kyushu University, Fukuoka, Japan, 8.Department of Pediatrics, Jichi Medical University of Medicine, Tochigi, Japan, 9.Department of Pediatrics, Ehime University, Toon, Japan)